How much is Rampart Bioscience worth in 2026?

Rampart Bioscience has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Rampart Bioscience raised?

Rampart Bioscience has raised N/A in total funding across 1 funding rounds.

Rampart Bioscience

Drug Discovery

Rampart Bioscience valuation and funding history | Last updated: September 11, 2023 | 1 funding rounds

Current Valuation

N/A

As of September 11, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$85.0M

Last Funding

Sep 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 11, 2023	Early Stage VC (Series A)	$85.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Rampart Bioscience is currently valued at N/A as of September 11, 2023.

Track Rampart Bioscience Valuation Updates

Get notified when Rampart Bioscience raises new funding or valuation changes

Explore More Data

Detailed analysis for Rampart Bioscience

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Rampart Bioscience's valuation history, funding rounds, and growth metrics.

No credit card required

What is Rampart Bioscience Worth in 2026?

Rampart Bioscience is a leading private company in the Drug Discovery sector. Track Rampart Bioscience's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Rampart Bioscience Valuation is Determined

Private company valuations like Rampart Bioscience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.